Bruker Corporation
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +366.0% | -89.4% | -95.0% | +3,390.9% | +394.8% | -65.8% | -296.2% | – | – | -69.0% | -208.7% | – | |
| – | +40.2% | -7.0% | +30.3% | +12.8% | +3.7% | -4.7% | +11.3% | -0.7% | +4.3% | +0.3% | -0.5% | – | |
| – | +8.8% | -14.5% | +30.2% | -8.7% | +7.9% | – | – | – | – | – | – | – | |
| – | – | -152.3% | – | – | – | -89.8% | -1,823.7% | – | – | -119.5% | – | – | |
| – | +17.1% | -32.1% | +15.0% | +32.5% | +12.6% | -29.2% | -18.1% | -1.9% | +8.1% | +7.1% | +19.0% | – | |
| – | -75.9% | +715.5% | +335.5% | -94.9% | -10.4% | -56.9% | +249.0% | -73.9% | +133.2% | -28.5% | -36.3% | – | |
| – | -1.4% | +0.0% | +5.5% | -1.3% | +0.0% | +1.3% | -1.3% | -100.0% | – | +5.7% | -0.5% | – | |
| – | -36.6% | -100.0% | – | – | – | – | -100.0% | – | -100.0% | – | – | – | |
| – | – | – | – | – | -723.3% | -38.8% | – | -506.2% | -65.3% | +25.4% | – | – | |
| – | -35.8% | – | +661.9% | -100.2% | +2,677.8% | -31.7% | – | +170.6% | -164.9% | +22.3% | – | – | |
| – | – | -218.9% | – | – | – | -97.1% | -9,250.0% | – | -97.1% | -2,951.7% | – | – | |
| – | +911.6% | -99.8% | -5,975.0% | – | +2,543.1% | -74.6% | -481.5% | – | – | -77.3% | -326.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.